Exhibit 10.1


 


Exhibit A


 


NEITHER THE NOTES NOR THE UNDERLYING COMMON
SHARES FOR THE NOTES OR WARRANTS HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”).
NEITHER THE NOTES NOR THE WARRANTS MAY BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION
STATEMENT. INVESTMENT IN THE SECURITIES OFFERED HEREBY INVOLVES A HIGH DEGREE OF RISK AND
IMMEDIATE SUBSTANTIAL DILUTION. PLEASE REVIEW THE RISK FACTOR DOCUMENT ATTACHED TO THE TERM SHEET.


 


THE OFFERING IS BEING MADE SOLELY TO “ACCREDITED
INVESTORS”, AS SUCH TERM IS DEFINED IN REGULATION D UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”)
OR FOREIGN RESIDENTS UNDER REGULATION S. NEITHER THE UNITS OR THE SHARE SHARES OF COMMON STOCK UNDERLYING SUCH UNITS HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OR THE SECURITIES LAW OF ANY STATE OR OTHER JURISDICTION AND WILL ONLY BE OFFERED AND SOLD
IN RELIANCE ON AVAILABLE EXEMPTIONS THEREFROM


 


THE
SECURITIES OFFERED HEREBY HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION, ANY STATE SECURITIES
COMMISSION OR EQUIVALENT AUTHORITIES OF ANY OTHER JURISDICTION NOR HAVE ANY SUCH AUTHORITIES PASSED UPON, CONFIRMED OR ENDORSED
THE MERITS OF THE OFFERING OR THE ACCURACY OR THE ADEQUACY OF THIS MEMORANDUM. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.


 


Redwood Scientific Technologies, Inc., a
Nevada corporation (the “Company”) hereby offers (the “Offering”)
up to $1,500,000 (the “Maximum Offering”) Units consisting of secured convertible Notes and Warrants . Each Unit is
being offered on a “best efforts” basis to selected, qualified accredited investors during an offering period expiring
on January 30, 2015 (the “Offering Period”). The Offering Period may be extended for thirty (30) days at the Company's
sole discretion; the Company need not give notice to any investors or potential investors if the Offering Period is so extended.
The Company reserves the right to terminate the Offering at any time. A minimum of $25,000 is necessary to participate in this
Offering, subject to smaller investments with the consent of the Company. 


 


REDWOOD SCIENTIFIC
TECHNOLOGIES, INC.


UNIT PURCHASE AGREEMENT


 


This UNIT PURCHASE AGREEMENT
(this “Agreement”) is dated as of December [ ], 2014 by and among Redwood Scientific Technologies, Inc., a Nevada
corporation (the “Company”), and each of the Purchasers whose names are set forth on Exhibit A hereto
(individually, a “Purchaser” and collectively, the “Purchasers”).


 


W
I T N E S E T H:


 


WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities
Act”) and/or Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser,
severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement;
and


 


WHEREAS, the Company is offering
under the Term Sheet dated ____________, 2014 (the Term Sheet”) Units consisting of a one (1) year secured convertible note
(individually a “Note” and collectively, the “Notes”) and warrants (the “Warrants”)
to purchase shares of our common stock for a maximum of $1,500,000, (the “Maximum Offering Amount,” the final
offering amount being hereinafter referred to as the “Financing Transaction”).


 



     

     

    

  


WHEREAS, the Company, ___________
(the Company’s wholly-owned subsidiary) are agreeing to provide collateral to the Purchasers to secure the repayment of the
Notes, subject to the terms and conditions of a Security Agreement, among the Company and the Purchasers, the form of which is
attached as Exhibit F hereto (as the same may be amended, supplemented or restated from time to time, the “Security
Agreement”).


 


AGREEMENT


  


NOW, THEREFORE, in
consideration of and subject to the mutual agreements, terms and conditions herein contained the receipt and sufficiency of which
are hereby acknowledged, the Company and Purchaser agree as follows:


 


		1.	PURCHASE AND SALE OF UNITS (NOTES AND WARRANTS)


 


1.1        Purchase
and Sale of Notes. Subject to the terms and conditions set forth herein, the Company is offering to each Purchaser the
number of Units set forth opposite such Purchaser’s name as set forth on Exhibit A hereto, consisting of up to $1,500,000
secured convertible Notes, in substantially the form attached hereto as Exhibit C and the Warrant, substantially in the
form attached hereto as Exhibit D. The Notes are convertible into shares of the Company’s common stock, par value
$0.01 per share (the “Common Stock” and the shares of Common Stock underlying the Notes are referred to as the
“Note Shares”) at a conversion price of $2.00 per share, subject to adjustment, and the three year warrant (the
“Warrant”) to purchase shares of Common Stock is exercisable at an exercise price of $2.50 per share (the shares
of Common Stock underlying the Warrants are referred to as the “Warrant Shares,” together with the Note Shares,
the “Shares”). The terms and provisions of the Notes and Warrants are set forth therein. The Notes, Units, Warrants
and Shares are sometimes collectively referred to herein as the “Securities.” The purchase price of each Note
shall be equal to the principal amount of such Note (the “Purchase Price”) and a
minimum Purchase Price of $25,000 is necessary to participate in this Offering, subject to smaller investments with the consent
of the Company.


 


1.2        Closing. The
closing of the transactions contemplated hereby shall take place on a rolling close basis, so long as least $25,000 (the “Minimum
Purchase Amount”) is received in the Company's Bank Account (as hereinafter defined) before any closing may occur unless
waived at the sole discretion of the Company. There is no minimum offering. The offering period and final closing date will be
no later than 4:00 p.m. EST, on January 30, 2015 (unless otherwise extended for an additional 30 days at the Company's sole
discretion) (the “Final Closing Date”), or at such other location, date and time, as may be agreed upon between
Purchaser and the Company, or by facsimile or other electronic means (such closing being called the “Closing”
and such date and time being called the “Closing Date”). The Purchaser shall not be entitled to notice
if the Closing is extended for an additional 30 days.


 



    	 	2	 



    


    

 


(a)        If the Company
receives the Minimum Purchase Amount on or before the Final Closing Date, the Company will hold an initial closing (the “Initial
Closing”). If the Company does not receive Minimum Purchase Amount by the Final Closing Date, the Offering will terminate
and all proceeds will be returned to subscribers without interest or deduction.


 


(b)        Following
the Initial Closing, the Company may hold subsequent Closings up to and including the Final Closing Date for all or any portion
of the remaining amount of the Offering not sold at the time of the Initial Closing or any subsequent Closing, provided, however,
that such subsequent Closings must occur no later than the Final Closing Date.


 


(c)        On the Initial
Closing Date and at each subsequent Closing until the Final Closing Date, each Purchaser shall deliver to the Company, via wire
transfer or a certified check, immediately available funds equal to such Purchaser’s Purchase Price as set forth on the Investor
Questionnaire executed by such Purchaser. The Company shall deliver to each Purchaser his or its respective Note, as determined
pursuant to the details first set forth above, and the Company and each Purchaser shall deliver the other items set forth in Section
4.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 4.1 and 4.2, the Closing
shall occur at the offices of Company Counsel or such other location as the parties shall mutually agree.


 


(d)        Purchasers
shall remit the Purchase Price as follows (collectively, the “Bank Account”):


 


WIRE TRANSFERS:


 


	 	Bank Name & Address:	 	[           ]
	 	ABA No.: 	 	[           ]
	 	Account No.:	 	[           ]
	 	Account Name:	 	[           ]


 


CHECKS:


 


	 	Made payable
to: 	Redwood Scientific Technologies, Inc.
	 	 	 
	 	Mail to: 	[            ]









   


(e)        All
such checks
and wire
transfers
remitted
to the Company
shall
be accompanied
by information identifying
each Purchaser, subscription,
the Purchaser’s
social security
or taxpayer
identification
number and
address.
 


 


(f)        Upon completion
of the Minimum Purchase Amount and until the Final Closing Date, the Purchasers shall continue to wire funds and/or deliver checks
payable to the Bank Account. At each subsequent Closing to be held on or before the Final Closing Date, all additional subscription
proceeds from the sale of Notes in excess of the Minimum Purchase Amount, net of any commissions or other offering expenses, will
be remitted to the Company.


 






    	 	3	 



    


    

 


		2.	REPRESENTATIONS AND WARRANTIES OF THE COMPANY


 


The
Company represents and warrants to Purchasers that:


 


2.1        The Company and each
subsidiary is a company duly organized, validly existing and in good standing under the laws of the state of Nevada. The Company
and each subsidiary is not in violation of any of the provisions of its articles of incorporation, by-laws or other organizational
or charter documents, each as may be amended (the “Internal Documents”). Except as described in the Term Sheet,
the Company has no subsidiaries and does not have an equity interest in any other firm, partnership, association or other entity.
The Company is qualified to transact business as a foreign corporation and is in good standing under the laws of each jurisdiction
where the location of its properties or the conduct of its business makes such qualification necessary, except where the failure
to be so qualified would not have a material adverse effect on the business, assets, liabilities, results of operations, condition
(financial or otherwise), properties or prospects of the Company. 


 


2.2        The Company has all
power and authority to: (i) conduct its business as presently conducted and as proposed to be conducted as described in the Term
Sheet; (ii) enter into and perform its obligations under this Agreement, Note, Warrant, Security Agreement and Registration Rights
Agreement (collectively, the “Transaction Documents”); and (iii) issue, sell and deliver the Units. The execution and
delivery of each of the Transaction Documents and the issuance, sale and delivery of the Units has been duly authorized by all
necessary corporate action. The Transaction Documents have been duly executed and when delivered will constitute upon due execution
and delivery, will constitute, valid and binding obligations of the Company, enforceable against the Company in accordance with
its terms except as enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar
laws now or hereafter in effect relating to or affecting creditors’ rights generally, including the effect of statutory and
other laws regarding fraudulent conveyances and preferential transfers, and except that no representation is made herein regarding
the enforceability of the Company’s obligations to provide indemnification and contribution remedies under the securities
laws and subject to the limitations imposed by general equitable principles (regardless of whether such enforceability is considered
in a proceeding at law or in equity).


 


2.3        The Securities will
be duly and validly issued, fully paid and non-assessable, and free from all taxes or liens with respect to the issue thereof and
shall not be subject to preemptive rights, rights of first refusal and/or other similar rights of stockholders of the Company and/or
any other person.


 


2.4        Capitalization.  The
capitalization of the Company is as set forth on the Term Sheet, which provides that there are 5,000,000 shares of Common Stock
issued and outstanding as of the date of this Agreement and up to 5% of the then outstanding shares of common stock, but no more
than 250,000 shares reserved under the Company’s equity incentive plan. Except as set forth on the Term Sheet, the Company
has not issued any other shares of Common Stock or common stock equivalents since its inception.  Except as pursuant to this
Agreement, no person has any right of first refusal, preemptive right, right of participation, or any similar right to participate
in the transactions contemplated by the Transaction Documents.  Except as a result of the purchase and sale of the Securities
and except as otherwise set forth on the Term Sheet, there are no outstanding options, warrants, scrip rights to subscribe to,
calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable
or exchangeable for, or giving any person any right to subscribe for or acquire any shares of Common Stock, or contracts, commitments,
understandings or arrangements by which the Company or any subsidiary is or may become bound to issue additional shares of Common
Stock or common stock equivalents. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued,
fully paid and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding
shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities.  No further
approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities.


 



    	 	4	 



    


    

 


2.5        Other than as expressly
disclosed in the Term Sheet, no action, suit or proceeding by or before any court or governmental agency, authority or body
or any arbitrator involving the Company or its property is pending or, to the best knowledge of the Company, threatened that (i)
could reasonably be expected to have a material adverse effect on the performance of this Agreement or the other Transaction Documents
by the Company or the consummation of any of the transactions contemplated hereby or thereby, and/or (ii) could reasonably be expected
to have a material adverse effect on the Company’s operations.


 


2.6        The Company is not
in (i) violation or default of any provision of its Internal Documents; (ii) default or material violation of the terms of any
indenture, contract, lease, mortgage, deed of trust, note agreement, loan agreement or other agreement, obligation, condition,
covenant or instrument to which it is a party or bound or to which its property is subject; and/or (iii) default or material violation
of any statute, law, rule, regulation, judgment, order or decree applicable to the Company of any court, regulatory body, administrative
agency, governmental body, arbitrator or other authority having jurisdiction over the Company or any of its properties, as applicable.


 


2.7        The Company has filed
all U.S. federal, state and local tax returns that are required to be filed or has requested extensions thereof and has paid all
taxes required to be paid by it and any other assessment, fine or penalty levied against the Company, to the extent that any of
the foregoing is due and payable, except for any such assessment, fine or penalty that is currently being contested in good faith
and except as set forth in or contemplated in the Term Sheet.


 


2.8        Assuming the accuracy
of the Purchaser’s representations and warranties set forth in this Agreement, no registration under the Securities Act of
the Units is required for the offer and sale of the Securities to the Purchaser in the manner contemplated herein and in the Term
Sheet.


 


2.9        The Company shall
file a Form D with respect to the Securities as required under Regulation D. The Company shall legally qualify the Securities for
sale to the Purchasers in each Closing , as required under applicable securities or “blue sky” laws of the states of
the United States (or obtain an exemption from such qualification), and shall pay all fees and expenses of such counsel
in connection therewith, including, but not limited to, all state filing fees and such counsel’s legal fees and expenses.


 


2.10       The proceeds from
the sale of the Units shall be used by the Company in the manner set forth under “Use of Proceeds” in the Term
Sheet.


 


2.11        None of the information
set forth in the Term Sheet contains any untrue statement of material fact or omits to state any material fact necessary in order
to make the statements made herein or therein, in light of the circumstances under which they were made, not misleading


 


2.12        No Conflict.
The execution and delivery of this Agreement does not, and the consummation of the transactions contemplated hereby will not, conflict
with, or result in any violation of, or default under (with or without notice or lapse of time, or both), or give rise to a right
of termination, cancellation or acceleration of any obligation or to a loss of a material benefit under any provision of any mortgage,
indenture, lease or other agreement or instrument, permit, concession, franchise, license, judgment, order, decree, statute, law,
ordinance, rule or regulation applicable to the Company or his properties or assets. Neither the execution and delivery of this
Agreement by the Company, nor the consummation of the transaction contemplated hereby, will result in the imposition of any security
interest upon the Shares.


 


2.13        Title to Securities.
The Company owns beneficially and of record, and has good and indefeasible title to, the Securities, free of all security interests,
pledges, charges, liens, or encumbrances of any kind.  The Company did not acquire any of the Securities in violation of any
preemptive right of any person. 


 



    	 	5	 



    


    

 


2.14        Securities Compliance
and Restricted Shares. All shares are restricted in compliance with Rule 144 promulgated under the Securities Act of 1933,
as amended.


 


2.15        No General Solicitation.
Neither the Company nor any person acting on behalf of the Company has offered or sold any of the Securities by any form of general
solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain other “accredited
investors” within the meaning of Rule 501 under the Securities Act.


 


2.16        Subsequent Closings/No
Integration. The Company has not made any prior offering nor sold any securities in any prior offering that would be integrated
pursuant to Rule 502(a) with the sale of the Securities and the transactions contemplated by this Agreement in which the Company
has not taken reasonable steps to verify that the purchasers of such securities were accredited investors. Further, the Company
covenants and agrees it shall take reasonable steps to verify that all investors are accredited investors in connection with (i)
the offer, sale and issuance of the Securities pursuant to this Agreement in all Closings and (ii) pursuant to any other future
securities offering that would be integrated with the transactions contemplated by this Agreement.


 


2.17        Certain Fees.
Except for the placement agent(s) as set forth in Section 7.1, no brokers fees, finder’s fees or financial advisory fees
or commissions will be payable by the Company with respect to the transactions contemplated by this Agreement and the other Transaction
Documents. The Company has agreed to pay the placement agent(s) a cash commission of eight percent (8%) of funds raised in the
Offering from persons introduced by such placement agent to the Company and a warrant commission of eight percent (8%) of the amount
of Notes sold in the Offering; placement agent warrants will have a term of three years and each will be exercisable for the purchase
of one share of Common Stock at an exercise price equal to the conversion price of the Notes. The Purchasers shall have no obligation
with respect to any fees or with respect to any claims made by or on behalf of other Persons for fees of a type contemplated in
this Section that may be due in connection with the transactions contemplated by the Transaction Documents.


 


2.18        Registration Rights.
Except as contemplated in the Registration Rights Agreement, the form of which is attached as
Exhibit E, no Person has any right to cause the Company to effect the registration under the Securities Act of any
securities of the Company or any subsidiaries.


 


		3.	REPRESENTATIONS
AND WARRANTIES OF PURCHASER


 


Purchaser hereby represents
and warrants to the Company as follows:


 


3.1        Organization.
Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the
laws of the jurisdiction of its incorporated or formed with full right, corporate, partnership, limited liability company or similar
power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and otherwise to
carry out its obligations hereunder and thereunder.


 


3.2        Authority.
Each Purchaser has the requisite power and authority to enter into and perform this Agreement and each of the other Transaction
Documents to which such Purchaser is a party and to purchase the Securities being sold to it hereunder. The execution, delivery
and performance of this Agreement and each of the other Transaction Documents to which such Purchaser is a party by such Purchaser
and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all necessary corporate,
partnership or limited liability company action, and no further consent or authorization of such Purchaser or its Board of Directors,
stockholders, partners, members, or managers, as the case may be, is required. This Agreement and each of the other Transaction
Documents to which such Purchaser is a party has been duly authorized, executed and delivered by such Purchaser and constitutes,
or shall constitute when executed and delivered, a valid and binding obligation of such Purchaser enforceable against such Purchaser
in accordance with the terms hereof.


 






    	 	6	 



    


    

 


3.3        Purchase Entirely
for Own Account. This Agreement is made with Purchaser in reliance upon Purchaser’s representation to the Company, which
by Purchaser’s execution of this Agreement, Purchaser hereby confirms that the Securities to be acquired by Purchaser will
be acquired for investment for Purchaser’s own account, not as a nominee or agent, and not with a view to the resale or distribution
of any part thereof, and that Purchaser has no present intention of selling, granting any participation in, or otherwise distributing
the same. By executing this Agreement, Purchaser further represents that Purchaser does not presently have any contract, undertaking,
agreement or arrangement with any Person to sell, transfer or grant participations to such Person or to any third Person, with
respect to any of the Securities.


 


3.4        Purchaser Status.
At the time Purchaser was offered the Securities, it was, and as of the date hereof it is, and on each date on which it converts
the Note and exercises the Warrants it will be either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2),
(a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a)
under the Securities Act. Such Purchaser is not required to be registered as a broker-dealer under Section 15 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) or (iii) “non U.S. Person” as defined under Regulation
S of the Securities Act. The Purchaser has truthfully
and
accurately
completed
the Investor Questionnaire requested in
this Agreement, attached as Exhibit B (and by signing this Agreement is deemed to have signed the Investor Questionnaire),
which is hereby incorporated by reference, and
will submit to
the Company such
further assurances
of such status
as may be
reasonably
requested
by the Company.


 


3.5        Experience of Purchaser.
Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and
financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has
so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk of an investment in the Securities
and is able to afford a complete loss of such investment.


 


3.6        Ability to Bear
Risk. Purchaser understands and agrees that purchase of the Securities is a high risk investment and Purchaser is able to afford
and bear an investment in a speculative venture having the risks and objectives of the Company, including a risk of total loss
of such investment. Purchaser must bear the substantial economic risks of the investment in the Securities indefinitely because
none of the Securities may be sold, hypothecated or otherwise disposed of unless subsequently registered under the Securities Act
and applicable state securities laws or an exemption from such registration(s) are available.


 


3.7        Disclosure of Information.
Purchaser has been given access to full and complete information regarding the Company and has utilized such access to Purchaser’s
satisfaction for the purpose of obtaining such information regarding the Company as Purchaser has reasonably requested. In particular,
Purchaser: (i) has received and thoroughly read and evaluated the Term Sheet, including the Risk Factor Disclosure Document attached
thereto (the “Risk Disclosure Document”) and any subsequent amendments or updates thereto, to which this Agreement
is attached as an exhibit, as well as the Transaction Documents; and (ii) has been given a reasonable opportunity to review such
documents as Purchaser has requested and to ask questions of, and to receive answers from, representatives of the Company concerning
the terms and conditions of the Securities and the business and affairs of the Company and to obtain any additional information
concerning the Company’s business to the extent reasonably available so as to understand more fully the nature of this investment
and to verify the accuracy of the information supplied. The Purchaser
is satisfied
that it has
received
adequate
information with respect
to all
matters which he/she/it consider
material
to its decision
to make
this investment.


 



    	 	7	 



    


    

 


3.8        No
other documents. In evaluating
the suitability
of an
investment in
the Company,
the Purchaser
has
not relied
upon any representation
or other information
(oral or
written)
other than as
stated
in this Agreement, the Term Sheet, the Note, the Warrant, the Security Agreement
substantially in the form of Exhibit F attached hereto, and the Registration Rights Agreement substantially in the form
of Exhibit E attached hereto, (collectively, the “Transaction Documents”) or
as contained
in documents
so furnished to
the Purchaser
by the
Company in writing.
The Purchaser specifically represents that it has not received an offering memorandum or similar document related to the Company,
its business or further describing the details of this offering of the Notes.


 


3.9        Restricted Securities.
Purchaser understands that neither the Securities nor the Shares have been, and will not be, registered under the Securities Act,
by reason of a specific exemption from the registration provisions of the Securities Act, which depends upon, among other things,
the bona fide nature of the investment intent and the accuracy of Purchaser’s representations as expressed herein. Purchaser
understands that the Securities are “restricted securities” under applicable U.S. federal and state securities laws
and that, pursuant to these laws, Purchaser must hold the Securities indefinitely unless they are registered with the Securities
and Exchange Commission and qualified by state authorities, or an exemption from such registration and qualification requirements
is available. Except as otherwise provided herein or the Registration Rights Agreement, Purchaser acknowledges that the Company
has no obligation to register or qualify the Securities. Purchaser further acknowledges that if an exemption from registration
or qualification is available, it may be conditioned on various requirements including, but not limited to, the time and manner
of sale, the holding period for the Securities, and on requirements relating to the Company that are outside of Purchaser’s
control, and which the Company is under no obligation and may not be able to satisfy.


 


3.10        No Public Market.
Purchaser understands that no public market now exists for the Securities and that the Company has made no assurances that a public
market will ever exist for the Securities.


 


3.11        Legends. Purchaser
understands that the Securities may be notated with one or all of the following legends:


 


(a)        “THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AND HAVE BEEN ACQUIRED FOR INVESTMENT AND
NOT WITH A VIEW TO, OR IN CONNECTION WITH, THE SALE OR DISTRIBUTION THEREOF. NO SUCH TRANSFER MAY BE EFFECTED WITHOUT AN EFFECTIVE
REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL IN A FORM SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS
NOT REQUIRED UNDER THE SECURITIES ACT OF 1933.”


 


(b)        Any legend
required by the securities laws of any state to the extent such laws are applicable to the Securities represented by the stock
certificate, instrument, or book entry so legended.


 


3.12        No General Solicitation.
The Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding
the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any
seminar or any other general solicitation or general advertisement.


 



    	 	8	 



    


    

 


3.13        Exculpation Among
Purchasers. Purchaser acknowledges that it is not relying upon any Person, other than the Company and its officers and directors,
in making its investment or decision to invest in the Company. Purchaser agrees that Purchaser is not liable to any other Purchaser
for any action heretofore taken or omitted to be taken by any of them in connection with the purchase of the Units.


 


3.14        Residence.
Purchaser is presently a bona fide resident of the state or country represented on the signature page hereof and has no present
intention of becoming a resident of any other state, country, or jurisdiction, and the address and Social Security Number/National
Insurance Number (or other applicable number) or Employer Identification Number/Corporate Tax Reference Number (or other applicable
number) set forth on the signature page hereof are Purchaser’s true and correct residential or business address and Social
Security Number/National Insurance Number (or other applicable number) or Employer Identification Number/Corporate Tax Reference
Number (or other applicable number).


 


3.15        U.S. Person.
If Purchaser is a “U.S. Person,” Purchaser: (i) if an individual, is at least 21 years of age; (ii) if an individual,
is a citizen or resident of the United States; (iii) has adequate means of providing for Purchaser’s current needs and personal
contingencies; (iv) has no need for liquidity in Purchaser’s investments; (v) maintains Purchaser’s principal residence
or business at the address shown on the signature page hereof; (vi) warrants that all investments in and commitments to non-liquid
investments are, and after Purchaser’s acquisition of the Securities will be, reasonable in relation to Purchaser’s
net worth and current needs; and (vii) warrants that any financial information that is provided herewith by Purchaser, or is subsequently
submitted by Purchaser at the request of the Company, does or will accurately reflect Purchaser’s financial condition with
respect to which Purchaser does not anticipate any material adverse change.


 


3.16        Confidential Information.
Each Purchaser agrees that such Purchaser and its employees, agents and representatives will keep confidential and will not disclose,
divulge or use (other than for purposes of monitoring its investment in the Company) any confidential information which such Purchaser
may obtain from the Company pursuant to financial statements, reports and other materials submitted by the Company to such Purchaser
pursuant to this Agreement, unless such information is (i) known to the public through no fault of such Purchaser or his or its
employees or representatives; (ii) becomes part of the public domain other than by a breach of this Agreement; (iii) becomes known
by the action of a third party not in breach of a duty of confidence; or (iv) is required to be disclosed to a third party pursuant
to any applicable law, government resolution, or decision of any court or tribunal of competent jurisdiction; provided, however,
that a Purchaser may disclose such information (i) to its attorneys, accountants and other professionals in connection with their
representation of such Purchaser in connection with such Purchaser’s investment in the Company, (ii) to any prospective permitted
transferee of the Securities, or (iii) to any general partner or affiliate of such Purchaser, so long as the prospective transferee
agrees to be bound by the provisions of this Section 3.16.


 


3.17        General. Such
Purchaser understands that the Notes are being offered and sold in reliance on a transactional exemption from the registration
requirements of federal and state securities laws and the Company is relying upon the truth and accuracy of the representations,
warranties, agreements, acknowledgments and understandings of such Purchaser set forth herein in order to determine the applicability
of such exemptions and the suitability of such Purchaser to acquire the Notes.


 






    	 	9	 



    


    

 


		4.	CONDITIONS PRECEDENT TO CLOSING


 


4.1        Conditions to
Obligations of Purchaser. Purchaser’s obligation to purchase the Notes pursuant to this Agreement is subject to the satisfaction
or waiver, at or prior to the Closing Date, of each of the following conditions:


 


(a)        Representations
and Warranties. The representations and warranties of the Company under Section 2 of this Agreement shall be true, complete
and correct on and as of the Closing Date, with the same effect as though such representations and warranties had been made on
and as of such date, and the Company shall have certified to such effect to Purchaser in writing.


 


(b)        No Order
Pending. There shall be no order, ruling, judgment or decree in effect, including of any regulatory agency, which would enjoin
or prohibit the transactions contemplated hereby.


 


(c)        Delivery
of Notes and Warrants. The Company shall have delivered a Note and Warrant.


 


(d)        Agreements,
Conditions and Covenants. The Company shall have performed or complied in all respects with all agreements, conditions and
covenants required by this Agreement to be performed or complied with by it on or before the Closing Date.


 


(e)        this Agreement
and all Transaction Documents duly executed by the Company.


 


4.2        Conditions to
Obligations of The Company. The Company’s obligation to sell and transfer the Shares pursuant to this Agreement is subject
to the satisfaction or waiver at or prior to the Closing Date of the following conditions:


 


(a)        This Agreement
executed by the Purchaser.


 


(b)        The Company
shall have received the Purchaser's Purchase Price.


 


(c)        Representations
and Warranties. The representations and warranties of Purchaser under Section 3 of this Agreement and in the Investor
Questionnaire, as well as the other information contained therein, shall be true, complete and correct on and as of the Closing
Date, with the same effect as though such representations and warranties had been made on and as of such date.


 


(d)        No Order
Pending. There shall be no order, ruling, judgment or decree in effect, including of any regulatory agency, which would enjoin
or prohibit the transactions contemplated hereby.


 


(e)        Agreements,
Conditions and Covenants. Purchaser shall have performed or complied in all respects with all agreements, conditions and covenants
required by this Agreement to be formed or complied with by it on or before the Closing Date, including but not limited to remittance
of the Purchase Price to the Company.


 


(f)        Investor
Questionnaire. The Purchaser shall have submitted a complete Investor Questionnaire to the Company as per the instructions
contained therein.


 


(g)        Board
Approval. The Company's Board of Directors shall have approved each of the forms of Transaction Documents and the Offering
contemplated hereby.


 






    	 	10	 



    


    

 





		5.	COVENANTS


 


The Company covenants with
each of the Purchasers as follows, which covenants are for the benefit of the Purchasers and their permitted assignees (as defined
herein):


 


5.1        Securities Compliance.
The Company shall notify the Commission in accordance with its rules and regulations, of the transactions contemplated by this
Agreement and the Transaction Documents, including filing a Form D with respect to the Units, as required under Regulation D and
applicable “blue sky” laws if such Units are offered pursuant to Rule 506 of Regulation D (“Regulation D”)
and shall take all other necessary action and proceedings as may be required and permitted by applicable law, rule and regulation,
for the legal and valid issuance of the Units to the Purchasers or subsequent holders.


 


5.2        Conversion and
Exercise Procedures. Each of the form of Notice of Exercise included in the Warrants and the form of Notice of Conversion included
in the Note set forth the totality of the procedures required of the Purchasers in order to exercise the Warrants or convert the
Note. No additional legal opinion, other information or instructions shall be required of the Purchasers to exercise their Warrants
or convert their Note into restricted shares of common stock. The Company shall honor exercises of the Warrants and conversions
of the Note and shall deliver Warrant Shares and Note Shares in accordance with the terms, conditions and time periods set forth
in the Transaction Documents


 


5.3        No Integrated Offerings.
The Company shall not make any offers or sales of any security (other than the securities being offered or sold hereunder) under
circumstances that would require registration of the securities being offered or sold hereunder under the Securities Act.


 


5.4        Registration Rights.
The Purchasers are eligible for the registration rights set forth in the Registration Rights Agreement.


 


5.5        Intentionally Left
Blank


 


5.6        Independent Nature
of Purchasers' Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not
joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance of the
obligations of any other Purchaser under any Transaction Document. The decision of each Purchaser to purchase Securities pursuant
to the Transaction Documents has been made by such Purchaser independently of any other Purchaser and independently of any information,
materials, statements or opinions as to the business, affairs, operations, assets, properties, liabilities, results of operations,
condition (financial or otherwise) or prospects of the Company which may have been made or given by any other Purchaser or by any
agent or employee of any other Purchaser, and no Purchaser and none of its agents or employees shall have any liability to any
other Purchaser (or any other Person) relating to or arising from any such information, materials, statements or opinions. Nothing
contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be
deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a
presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by the Transaction Documents. Each Purchaser acknowledges that no other Purchaser has acted as agent for such Purchaser
in connection with making its investment hereunder and that no Purchaser will be acting as agent of such Purchaser in connection
with monitoring its investment in the Securities or enforcing its rights under the Transaction Documents. Each Purchaser shall
be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this Agreement
or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any Proceeding for such purpose. It is expressly understood and agreed that each provision contained in this Agreement
is between the Company and a Purchaser, solely, and not between the Company and the Purchasers collectively and not between and
among the Purchasers.


 



    	 	11	 



    


    

 


5.7        Further Assurances.  The
Company shall execute any and all further documents, financing statements, agreements and instruments, and take all further action
(including filing Uniform Commercial Code, United States Patent and Trademark Office and other financing statements not later than
one (1) business day after the date hereof) that may be required under applicable law, or that the Purchasers may reasonably request,
in order to effectuate the transactions contemplated by this Agreement and in order to grant, preserve, protect and perfect the
validity and first priority of the security interests created or intended to be created by the Notes. From time to time, the Company
shall, at its cost and expense and subject to the terms of the Notes, promptly secure the Notes by pledging or creating, or causing
to be pledged or created, perfected security interests with respect to such of its assets and properties as the Purchasers shall
designate (it being understood that it is the intent of the parties that, except as set forth in the Notes, the obligations pursuant
to the Notes shall be secured by all the assets of the Company and its subsidiaries (including real and other properties acquired
subsequent to the Closing Date)). Such security interests and Liens will be created under this Agreement, the Security Agreement
and other security agreements, mortgages, deeds of trust and other instruments and documents in form and substance satisfactory
to the Purchasers, and the Company shall deliver or cause to be delivered to the Purchasers all such instruments and documents
as the Purchasers shall reasonably request to evidence compliance with this Section 5.6. The Company agrees to provide
such evidence as the Purchasers shall reasonably request as to the perfection and priority status of each such security interest
and Lien.  In furtherance of the foregoing, the Company will give prompt notice to the Purchasers of the acquisition
by it or any of its subsidiaries of any property (or any interest in property) having a value in excess of $500,000.


 


5.8        Best Efforts.
The Company shall exert its best efforts to satisfy the closing conditions set forth in Section 4.1 hereof or cause such closing
conditions to be satisfied at or before the Closing.


 


		6.	OTHER AGREEMENTS OF THE PARTIES


 


6.1        Make Good.


 


(a)        In the event
the Company has less than $20,000,000 in gross revenue or less than $1 in earnings before interest, taxes, depreciation and amortization
(EBITDA) for the subsequent twelve months following the close of an aggregate of $6,000,000 in funding (including the gross proceeds
from this Offering) (such 12 month period, the “Make Good Period”), the Company shall issue the Purchasers additional
shares of common stock in an aggregate amount equal to twenty percent (20%) of the number of Shares issuable pursuant to this Offering
(such additional shares, the “Make Good Shares”) on a pro rata basis among the Purchasers.


 


(b)        The Company
shall use reasonable best efforts to distribute preliminary financial statements covering the Make Good Period within 45 days after
the end of the Make Good Period and audited financial statements, if requested by the Purchasers sixty days after written notice
of the request, for purposes of determining whether the Company is required to issue the Make Good Shares. If the Company fails
to use reasonable best efforts to distribute such financial statements containing the information necessary to calculate the Company’s
revenue, the number of Make Good Shares issuable shall instead be equal to one hundred percent (100%) of the number of Shares issuable
pursuant to this Offering, issued on a pro rata basis among the Purchasers. 


 



    	 	12	 



    


    

 


(c)        If the Company
and the Purchasers disagree as to how many Make Good Shares are due, then such dispute shall be resolved as follows: in the case
of a dispute as to the arithmetic calculation of Make Good Shares due, the Company shall submit the disputed determinations or
arithmetic calculations via facsimile within one (1) Business Day of receipt, or deemed receipt, of the event giving rise to such
dispute, as the case may be, to the Purchaser.  If the Purchaser and the Company are unable to agree upon such determination
or calculation within one (1) Business Day of such disputed determination or arithmetic calculation being submitted to the Purchaser,
then the Company shall, within one Business Day submit via facsimile the disputed arithmetic calculation of the interest payment
to the Company’s independent, outside accountant.  The Company shall cause the accountant to perform the determinations
or calculations and notify the Company and the Purchaser of the results no later than five (5) Business Days from the time it receives
the disputed determinations or calculations. Such accountant’s determination or calculation shall be binding upon all parties
absent demonstrable error.  The party whose calculation is furthest from the accountant’s determination or calculation,
shall be obligated to pay the fees and expenses of such accountant.



 


		7.	MISCELLANEOUS


 


7.1        Fees
and Expenses. The Company has engaged Halen Capital Management, Inc. and its affiliated entities as exclusive placement agent
for the Company (the “Placement Agent(s)”). The Company has agreed to pay the Placement Agent(s), in connection
with sales of the Securities made to Persons introduced to the Company by any of them, respectively, the fees set described in
Section 2.17 above and legal fees related hereto up to $[ ]. Except as expressly set forth in the Transaction Documents to the
contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all
other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement.
The Company shall pay all Transfer Agent fees, stamp taxes and other taxes and duties levied in connection with the delivery of
any Securities to the Purchasers.


 


7.2        Representations
and Warranties. The representations and warranties of the Company and Purchaser shall survive the Closing and delivery of the
Securities and the Warrants.


 


7.3        Indemnification.
Purchaser agrees to indemnify and hold harmless the Company and the Placement Agent and each director, officer or agent thereof
from and against any and all losses, damages, liabilities and expenses arising out of or in connection with any breach of, or inaccuracy
in, any representation or warranty of the undersigned, whether contained in this Agreement or otherwise.


 


7.4        Waiver, Amendment.
Neither this Agreement nor any provisions hereof shall be waived, modified, changed, discharged or terminated except by an instrument
in writing signed by the party against whom any waiver, modification, change, discharge or termination is sought.


 


7.5        Assignability.
Neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable
by either Company or Purchaser without the prior written consent of each other party.


 


7.6        Section and Other
Headings. The section headings contained in this Agreement are for reference purposes only and shall not affect in any way
the meaning or interpretation of this Agreement.


 



    	 	13	 



    


    

 


7.7        Governing Law and
Jurisdiction. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of
Nevada, without regard to principles of conflicts of laws thereof. Each of the parties hereto expressly and irrevocably (1) agree
that any legal suit, action or proceeding arising out of or relating to this Agreement will be instituted exclusively in either
the State Courts in Pinellas County, Florida, or in the United States District Court for the Middle District of Florida, (2) waive
any objection they may have now or hereafter to the venue of any such suit, action or proceeding, and (3) consent to the in persona
jurisdiction of either the State Court in Pinellas County, Florida, or in the United States District Court for the Middle District
of Florida in any such suit, action or proceeding. Each of the parties hereto further agrees to accept and acknowledge service
of any and all process which may be served in any such suit, action or proceeding in either the State Court in Pinellas County,
Florida, or in the United States District Court for the Middle District of Florida agree that service of process upon it mailed
by certified mail to its address will be deemed in every respect effective service of process upon it, in any such suit, action
or proceeding.


 


7.8        Counterparts.
This Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed to be
an original and all of which together shall be deemed to be one and the same agreement.


 


7.9        Notices. All
notices and other communications provided for herein shall be in writing and shall be deemed to have been duly given if delivered
personally or sent by registered or certified mail, return receipt requested, postage prepaid:


 







	 	(a)	if to Purchaser:
	 	 	 
	 	 	The address included on the Investor Questionnaire. 
	 	 	 
	 	(b)	if to The
Company:
	 	 	 
	 	 	Redwood
Scientific Technologies, Inc.
	 	 	[ ]
	 	 	Attn:   [ ]


 


with
a copy to (which shall not constitute notice):


 





	 	 	Hunter Taubman Weiss, LLP
	 	 	130 W. 42nd Street, Suite 1050
	 	 	New York, NY 10036
	 	 	Attn: Rachael Schmierer



  


7.10        Binding Effect.
The provisions of this Agreement shall be binding upon and accrue to the benefit of the parties hereto and their respective heirs,
legal representatives, permitted successors and assigns.


 


7.11        Entire Agreement.
This Agreement (including the Exhibits hereto), the Investor Questionnaire and the Transaction Documents constitute the full and
entire understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral
agreement relating to the subject matter hereof existing between the parties are expressly canceled.


 


7.12        Severability.
If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal,
void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full
force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated
by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that
they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be
hereafter declared invalid, illegal, void or unenforceable.


 



    	 	14	 



    


    

 


7.13        Remedies.
In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, the Purchaser
and the Company will be entitled to specific performance under this Agreement. The parties agree that monetary damages may not
be adequate compensation for any loss incurred by reason of any breach of obligations contained in this Agreement and hereby agree
to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at law would
be adequate.


 


7.14        Construction.
The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise this Agreement
and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party
shall not be employed in the interpretation of this Agreement or any amendments thereto.


 


7.15        WAIVER OF JURY
TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH
KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY, IRREVOCABLY
AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.


 


7.16        Replacement Of
Securities. If any certificate or instrument evidencing any Unit is mutilated, lost, stolen or destroyed, the Company shall
issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor,
a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or
destruction and customary and reasonable indemnity, if requested. The applicants for a new certificate or instrument under such
circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement Unit. If a replacement
certificate or instrument evidencing any Unit is requested due to a mutilation thereof, the Company may require delivery of such
mutilated certificate or instrument as a condition precedent to any issuance of a replacement.


 


7.17        Waivers. No
waiver by any party of any default with respect to any provision, condition or requirement of this Agreement and the other Transaction
Documents shall be deemed to be a continuing waiver in the future or a waiver of any other provisions, condition or requirement
hereof and thereof, nor shall any delay or omission of any party to exercise any right hereunder and thereunder in any manner impair
the exercise of any such right accruing to it thereafter.


 


7.18        Successors And
Assigns. This Agreement may not be assigned by a party hereto without the prior written consent of the Company or the Purchaser,
as applicable, provided, however, that, subject to federal and state securities laws and as otherwise provided in
the Transaction Documents, a Purchaser may assign its rights and delegate its duties hereunder in whole or in part (i) to a third
party acquiring all or substantially all of its Shares or Warrants in a private transaction or (ii) to an affiliate, in each case,
without the prior written consent of the Company or the other Purchasers, after notice duly given by such Purchaser to the Company
provided, that no such assignment or obligation shall affect the obligations of such Purchaser hereunder and that such assignee
agrees in writing to be bound, with respect to the transferred securities, by the provisions hereof that apply to the Purchasers.
The provisions of this Agreement shall inure to the benefit of and be binding upon the respective permitted successors and assigns
of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto
or their respective successors and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement,
except as expressly provided in this Agreement.


 



    	 	15	 



    


    

 


7.19        Signature Page.
It is hereby agreed that the execution by a Purchaser of this Agreement, in the place set forth herein, will constitute agreement
to be bound by the terms and conditions hereof. It is hereby agreed by the parties hereby that the execution by the Purchaser of
this Agreement, in the place set forth herein, will be deemed and constitute the agreement by the Purchaser to be bound by all
of the terms and conditions of this Agreement, as well as by the Investor Questionnaire, the Notes, the Security Agreement,
the Warrants, the Registration Rights Agreement and all of the other documents constituting the Transaction Documents and will
be deemed and constitute the execution by the Purchaser of all such Transaction Documents without requiring the Purchaser's separate
signature on any of such Transaction Documents. Further, such signature will constitute the Purchaser's agreement that the information
contained in the Investor Questionnaire is complete and accurate.


 





[signature
pages follows]


 






    	 	16	 



    


    

 


IN WITNESS
WHEREOF, Company and Purchaser have executed this Agreement as of the date first written above.


 





	 	REDWOOD
    SCIENTIFIC TECHNOLOGIES, INC.
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:	 


 


[REMAINDER OF PAGE INTENTIONALLY
LEFT BLANK


SIGNATURE PAGE FOR PURCHASER
FOLLOWS]


 






    	 	17	 



    


    

 


REDWOOD
SCIENTIFIC TECHNOLOGIES, INC.


PURCHASER
SIGNATURE
PAGE TO


PURCHASE
AGREEMENT


  


Purchaser
hereby
elects
to purchase
a total
of $_____________ Units. 


 


Date
(NOTE:
To be completed
by the
Purchaser):____________________, 20__


 


 


 








If
the Purchaser
is an INDIVIDUAL,
and if purchased
with a SPOUSE, or as JOINT


TENANTS,
as TENANTS
IN COMMON, or
as COMMUNITY
PROPERTY:


 





	 		 		 
	 	Print
    Name(s)	 	Social Security
    Number(s)	 
	 	 	 	 	 
	 		 	 	 
	 	Signature(s)
    of Purchaser(s)	 	Signature	 
	 	 	 	 	 
	 		 	 	 
	 	Date	 	Address	 



 


If
the Purchaser
is a PARTNERSHIP,
CORPORATION,
LIMITED
LIABILITY
COMPANY or TRUST:


 





	 		 	 	 
	 	Name of
    Partnership,	 	Federal
    Taxpayer	 
	 	Corporation,
    Limited	 	Identification
    Number	 
	 	Liability Company
    or Trust	 	 	 
	 	 	 	 	 
	By:  		 	 	 
		Name:	 	State
    of Organization	 
	 	Title:	 	 	 
	 	 	 	 	 
	 		 	 	 
	 	Date	 	Address	 



 






    	 	18	 



    


    

 


EXHIBIT A TO THE

NOTE PURCHASE AGREEMENT


 


Purchasers


 


	Investor
    Name	Investment

Amount	Convertible

Note	Warrant
	 	 	 	 
	 	 	 	 
	 	 	 	 
	Total	 	 	 





 






     


     


    

 


Exhibit B


 


Investor Questionnaire


 






     


     


    

 


Exhibit C


 


Form of Note


 






     


     


    

 


Exhibit D


 


Form of Warrant


 






     


     


    

 


Exhibit E


 


Registration Rights Agreement


 






     


     


    

 


Exhibit F


 


Security Agreement